Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Schmitz K, Ko E.: Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in the National Surgical Quality Improvement Program International Journal of Gynecological Cancer 27(3): : 581-587,2017.
Esselen KM, Cronin AM, Bixel K, Bookman MA, Burger RA, Cohn DE, Christea M, Griggs JJ, Levanback CF, Mantia-Smaldone G, Meyer LA, Matulonis UA, Niland JC, Sun C, O'Malley DM, Wright AA: Use of CA-125 Tests and CT Scans for Surveillance in Ovarian Cancer:
Value-based Cancer Care? JAMA Oncology 2 (11): 1427-33,2016.
Dean LT, Zhang X, Latif N, Giuntoli R, Lin L, Haggerty A, Kim S, Shalowitz D, Stashwick C, Simpkins F, Burger R, Morgan M, Ko E, Schmitz KS: Race-Based Disparities in Loss of Functional Independence after Hysterectomy for Uterine Cancer Support Care Cancer 24 (8): 3573-80,2016.
Secord AA; Tritchler D; Liu Y; Starr MD; Brady JC; Lankes HA; Hurwitz H; Mannel RS; Tewari KS; O’Malley DM; Gray HJ; Bakhum-Gamez JN; Fujiwara K; Boente M; Deng W; Burger RA; Birrer MJ; Nixon AB: Prognostic and predictive blood-based biomarkers (BMs) in patients (pts) with advanced epithelial ovarian cancer (EOC) treated with carboplatin-paclitaxel (CP) +/- bevacizumab (BEV); Results from GOG-0218. American Society of Clinical Oncology Annual Meeting, Chicago, IL. (Abstract) : 2016.
O'Cearbhaill RE, Mantia-Smaldone G, Gunderson C, Morgan M, Burger R, Sabbatini P, Cattanuzza F, Fischer M, Kapoun AM, Xu L, Dupont J, Brachmann RK, Uttamsingh S, Farooki A, Moore K.: Phase 1b of WNT inhibitor ipafricept (IPA, decoy receptor for WNT ligands) with carboplatin (C) and Paclitaxel (P) in Recurrent platinum-sensitive ovarian cancer (OC). Poster presentation at 2016 American Society of Clinical Oncology Annual Meeting, Chicago, IL (Abstract) Abstract : 2016.
Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ.: Inherited mutations in women with ovarian carcinoma. JAMA Oncology 2 (4): 482-90,2016.
Koenig AF, Latif NA, Hummel CS, Zhang X, Morgan MA, Burger RA, Ko EM, Giuntoli II RL: Low intraperitoneal port placement rate in ovarian cancer patients: A population-based national assessment. 47th Annual Meeting on Women's Cancers, San Diego, CA (Abstract) : 2016.
Latif NA, Hummel CS, Zhang X, Giuntoli II RL, Morgan MA, Burger RA, Simpkins F, Kim SH, Schmitz K, Ko EM.: Ovarian cancer debulking by gynecologic oncologists alone versus multidisplinary surgical specialties: Is there a difference in outcomes? 47th Annual Meeting on Women's Cancers, San Diego, CA. (Abstract) : 2016.
Cory L, Latif NA, Zhang X, Giuntoli II RL, Kim SH, Simpkins F, Morgan MA, Burger RA, Schmitz K, Ko EM.: Postsurgical readmissions among women with gynecologic malignancies. 47th Annual Meeting on Women's Cancers, San Diego, CA (Abstract) : 2016.
George E, Kim H, Ragland R, Brown E, Butler L, Gilad O, Tanyi JL, Zhang R, Krepler C, Lee R, Morgan MA, Burger RA, Ko EM, Kim SH, Herlyn M, Simpkins F.: Capitalizing on synthetic lethality in homologous recombination-deficient high-grade serous ovarian cancers with a novel ATR inhibitor. 47th Annual Meeting on Women's Cancer, San Diego, CA (Abstract) : 2016.